[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100653228":3},{"organization":4,"outcomesModule":7,"designInfo":30,"detailedDescription":11,"studyPopulation":11,"armGroups":36,"interventions":48,"overallOfficials":11,"centralContacts":59,"locations":65,"responsibleParty":373,"collaborators":11,"id":375,"slug":376,"hasResults":377,"nctId":378,"briefTitle":379,"officialTitle":380,"acronym":11,"eligibilityCriteria":381,"healthyVolunteers":377,"sex":382,"minAge":383,"maxAge":11,"enrollmentInfo":384,"targetDuration":11,"studyType":387,"phases":388,"briefSummary":390,"conditions":391,"keywords":11,"overallStatus":393,"whyStopped":11,"lastUpdateSubmitDate":394,"lastUpdatePostDateStruct":395,"startDateStruct":398,"completionDateStruct":400,"leadSponsor":402,"locationsCount":403},{"fullName":5,"class":6},"Beijing InnoCare Pharma Tech Co., Ltd.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Progression-free survival (PFS) as assessed by Independent Review Committee (IRC).",null,"6 years",[14,16,18,20,22,24,26,28],{"measure":15,"description":11,"timeFrame":12},"Investigator-assessed PFS according to Lugano 2014.",{"measure":17,"description":11,"timeFrame":12},"IRC-assessed and investigators-assessed overall response rate (ORR) according to Lugano 2014",{"measure":19,"description":11,"timeFrame":12},"IRC-assessed and investigators-assessed complete response rate (CRR) according to Lugano 2014",{"measure":21,"description":11,"timeFrame":12},"IRC-assessed and investigators-assessed duration of response (DOR) according to Lugano 2014",{"measure":23,"description":11,"timeFrame":12},"IRC-assessed and investigators-assessed time to first response (TTR) according to Lugano 2014",{"measure":25,"description":11,"timeFrame":12},"Time to next treatment (TTNT)",{"measure":27,"description":11,"timeFrame":12},"Overall Survival (OS)",{"measure":29,"description":11,"timeFrame":12},"Eastern Cooperative Oncology Group (ECOG) performance status",{"allocation":31,"interventionModel":32,"interventionModelDescription":11,"primaryPurpose":33,"observationalModel":11,"timePerspective":11,"maskingInfo":34},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":35,"maskingDescription":11,"whoMasked":11},"NONE",[37,43],{"label":38,"type":39,"description":11,"interventionNames":40},"ICP-248 in combination with Orelabrutinib","EXPERIMENTAL",[41,42],"Drug: ICP-248","Drug: Orelabrutinib",{"label":44,"type":45,"description":11,"interventionNames":46},"Pirtobrutinib","ACTIVE_COMPARATOR",[47],"Drug: Pirtobrutinib",[49,54,56],{"type":50,"name":51,"description":52,"armGroupLabels":53,"otherNames":11},"DRUG","ICP-248","Administered orally",[38],{"type":50,"name":44,"description":52,"armGroupLabels":55,"otherNames":11},[44],{"type":50,"name":57,"description":52,"armGroupLabels":58,"otherNames":11},"Orelabrutinib",[38],[60],{"name":61,"role":62,"phone":63,"phoneExt":11,"email":64},"Alexia Lu","CONTACT","010-66609745","CO_HGRAC@innocarepharma.com",[66,83,97,111,121,135,149,163,177,187,201,211,225,239,253,267,281,290,296,310,319,335,349,363],{"facility":67,"status":11,"city":68,"state":69,"zip":70,"country":71,"countryCode":72,"cosmosGeoPoint":73,"geoPoint":78,"contacts":79},"The First Affiliated Hospital of Anhui Medical University","Hefei","Anhui","230022","China","CN",{"type":74,"coordinates":75},"Point",[76,77],117.28083,31.86389,{"lat":77,"lon":76},[80],{"name":81,"role":62,"phone":11,"phoneExt":11,"email":82},"Jian Ge","gejian52@163.com",{"facility":84,"status":11,"city":85,"state":86,"zip":87,"country":71,"countryCode":72,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Peking University Third Hospital","Beijing","Beijing Municipality","100083",{"type":74,"coordinates":89},[90,91],116.39723,39.9075,{"lat":91,"lon":90},[94],{"name":95,"role":62,"phone":11,"phoneExt":11,"email":96},"Hongmei Jing","bysyjhm@sina.com",{"facility":98,"status":11,"city":99,"state":100,"zip":101,"country":71,"countryCode":72,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Chongqing University Cancer Hospital","Chongqing","Chongqing Municipality","400030",{"type":74,"coordinates":103},[104,105],106.55771,29.56026,{"lat":105,"lon":104},[108],{"name":109,"role":62,"phone":11,"phoneExt":11,"email":110},"Yingyu Nan","nanxi221@sina.com",{"facility":112,"status":11,"city":99,"state":100,"zip":113,"country":71,"countryCode":72,"cosmosGeoPoint":114,"geoPoint":116,"contacts":117},"Xinqiao Hospital of Army Medical University","400037",{"type":74,"coordinates":115},[104,105],{"lat":105,"lon":104},[118],{"name":119,"role":62,"phone":11,"phoneExt":11,"email":120},"Xi Zhang","zhangxxi@sina.com",{"facility":122,"status":11,"city":123,"state":124,"zip":125,"country":71,"countryCode":72,"cosmosGeoPoint":126,"geoPoint":130,"contacts":131},"Fujian Cancer Hospital","Fuzhou","Fujian","350014",{"type":74,"coordinates":127},[128,129],119.30611,26.06139,{"lat":129,"lon":128},[132],{"name":133,"role":62,"phone":11,"phoneExt":11,"email":134},"HongMing He","811481521@qq.com",{"facility":136,"status":11,"city":137,"state":138,"zip":139,"country":71,"countryCode":72,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"Sun Yat-sen University Cancer Center","Guangzhou","Guangdong","636799",{"type":74,"coordinates":141},[142,143],113.25,23.11667,{"lat":143,"lon":142},[146],{"name":147,"role":62,"phone":11,"phoneExt":11,"email":148},"He Huang","huanghe@sysucc.org.cn",{"facility":150,"status":11,"city":151,"state":152,"zip":153,"country":71,"countryCode":72,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"The Fourth Hospital of Hebei Medical University","Shijiazhuang","Hebei","050011",{"type":74,"coordinates":155},[156,157],114.47861,38.04139,{"lat":157,"lon":156},[160],{"name":161,"role":62,"phone":11,"phoneExt":11,"email":162},"Lihong Liu","13831177920@163.com",{"facility":164,"status":11,"city":165,"state":166,"zip":167,"country":71,"countryCode":72,"cosmosGeoPoint":168,"geoPoint":172,"contacts":173},"Henan Cancer Hospital","Zhengzhou","Henan","450000",{"type":74,"coordinates":169},[170,171],113.64861,34.75778,{"lat":171,"lon":170},[174],{"name":175,"role":62,"phone":11,"phoneExt":11,"email":176},"Keshu Zhou","gcpzks@163.com",{"facility":178,"status":11,"city":165,"state":166,"zip":179,"country":71,"countryCode":72,"cosmosGeoPoint":180,"geoPoint":182,"contacts":183},"Henan Provincial People's Hospital","450003",{"type":74,"coordinates":181},[170,171],{"lat":171,"lon":170},[184],{"name":185,"role":62,"phone":11,"phoneExt":11,"email":186},"Zunmin Zhu","zhuzm1964@163.com",{"facility":188,"status":11,"city":189,"state":190,"zip":191,"country":71,"countryCode":72,"cosmosGeoPoint":192,"geoPoint":196,"contacts":197},"Tongji Hospital Tongji Medical College Huazhong University of Science and Technology","Wuhan","Hubei","430022",{"type":74,"coordinates":193},[194,195],114.26667,30.58333,{"lat":195,"lon":194},[198],{"name":199,"role":62,"phone":11,"phoneExt":11,"email":200},"Wei Jia","jiawei_tongji@163.com",{"facility":202,"status":11,"city":189,"state":190,"zip":203,"country":71,"countryCode":72,"cosmosGeoPoint":204,"geoPoint":206,"contacts":207},"Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital","430030",{"type":74,"coordinates":205},[194,195],{"lat":195,"lon":194},[208],{"name":209,"role":62,"phone":11,"phoneExt":11,"email":210},"Jun Fang","fangjunth@126.com",{"facility":212,"status":11,"city":213,"state":214,"zip":215,"country":71,"countryCode":72,"cosmosGeoPoint":216,"geoPoint":220,"contacts":221},"Hunan Cancer Hospital","Changsha","Hunan","410000",{"type":74,"coordinates":217},[218,219],112.97087,28.19874,{"lat":219,"lon":218},[222],{"name":223,"role":62,"phone":11,"phoneExt":11,"email":224},"Hui Zhou","zhouhui@hnca.org.cn",{"facility":226,"status":11,"city":227,"state":228,"zip":229,"country":71,"countryCode":72,"cosmosGeoPoint":230,"geoPoint":234,"contacts":235},"Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University","Nanjing","Jiangsu","210000",{"type":74,"coordinates":231},[232,233],118.77778,32.06167,{"lat":233,"lon":232},[236],{"name":237,"role":62,"phone":11,"phoneExt":11,"email":238},"Jingyan Xu","xjy1967@sina.com",{"facility":240,"status":11,"city":241,"state":242,"zip":243,"country":71,"countryCode":72,"cosmosGeoPoint":244,"geoPoint":248,"contacts":249},"The first Hospital of China Medical University","Shenyang","Liaoning","110801",{"type":74,"coordinates":245},[246,247],123.43278,41.79222,{"lat":247,"lon":246},[250],{"name":251,"role":62,"phone":11,"phoneExt":11,"email":252},"Xiaojing Yan","yanxiaojing_pp@hotmail.com",{"facility":254,"status":11,"city":255,"state":256,"zip":257,"country":71,"countryCode":72,"cosmosGeoPoint":258,"geoPoint":262,"contacts":263},"Shandong Cancer Hospital","Jinan","Shandong","250117",{"type":74,"coordinates":259},[260,261],116.99722,36.66833,{"lat":261,"lon":260},[264],{"name":265,"role":62,"phone":11,"phoneExt":11,"email":266},"Zengjun Li","zengjunli@163.com",{"facility":268,"status":11,"city":269,"state":270,"zip":271,"country":71,"countryCode":72,"cosmosGeoPoint":272,"geoPoint":276,"contacts":277},"Fudan University Shanghai Cancer Center","Shanghai","Shanghai Municipality","200032",{"type":74,"coordinates":273},[274,275],121.45806,31.22222,{"lat":275,"lon":274},[278],{"name":279,"role":62,"phone":11,"phoneExt":11,"email":280},"Wenhao Zhang","gaoguangxun@fmmu.edu.cn",{"facility":282,"status":11,"city":283,"state":284,"zip":285,"country":71,"countryCode":72,"cosmosGeoPoint":11,"geoPoint":11,"contacts":286},"The Second Affiliated Hospital of Xi'an Jiaotong University","Xian","Shanxi","710004",[287],{"name":288,"role":62,"phone":11,"phoneExt":11,"email":289},"Wanhong Zhao","13991365406@163.com",{"facility":291,"status":11,"city":283,"state":284,"zip":292,"country":71,"countryCode":72,"cosmosGeoPoint":11,"geoPoint":11,"contacts":293},"The First Affiliated Hospital of the PLA Air Force Military Medical University (Xijing Hospital)","710032",[294],{"name":295,"role":62,"phone":11,"phoneExt":11,"email":280},"Guangxun Gao",{"facility":297,"status":11,"city":298,"state":299,"zip":300,"country":71,"countryCode":72,"cosmosGeoPoint":301,"geoPoint":305,"contacts":306},"Sichuan Cancer Hospital","Chengdu","Sichuan","610041",{"type":74,"coordinates":302},[303,304],104.06667,30.66667,{"lat":304,"lon":303},[307],{"name":308,"role":62,"phone":11,"phoneExt":11,"email":309},"Huangming Hong","13570431657@163.com",{"facility":311,"status":11,"city":298,"state":299,"zip":300,"country":71,"countryCode":72,"cosmosGeoPoint":312,"geoPoint":314,"contacts":315},"West China Hospital of Sichuan University",{"type":74,"coordinates":313},[303,304],{"lat":304,"lon":303},[316],{"name":317,"role":62,"phone":11,"phoneExt":11,"email":318},"Jie Wang","42922155@qq.com",{"facility":320,"status":11,"city":321,"state":322,"zip":323,"country":71,"countryCode":72,"cosmosGeoPoint":324,"geoPoint":328,"contacts":329},"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences","Tianjin","Tianjin Municipality","300052",{"type":74,"coordinates":325},[326,327],117.17667,39.14222,{"lat":327,"lon":326},[330,333],{"name":331,"role":62,"phone":11,"phoneExt":11,"email":332},"Shuhua Yi","yishuhua@ihcams.ac.cn",{"name":334,"role":62,"phone":11,"phoneExt":11,"email":11},"Lugui Qiu",{"facility":336,"status":11,"city":337,"state":338,"zip":339,"country":71,"countryCode":72,"cosmosGeoPoint":340,"geoPoint":344,"contacts":345},"Yunnan Cancer Hospital","Kunming","Yunnan","650118",{"type":74,"coordinates":341},[342,343],102.71833,25.03889,{"lat":343,"lon":342},[346],{"name":347,"role":62,"phone":11,"phoneExt":11,"email":348},"Xiaopei Wang","cadillac570@163.com",{"facility":350,"status":11,"city":351,"state":352,"zip":353,"country":71,"countryCode":72,"cosmosGeoPoint":354,"geoPoint":358,"contacts":359},"The First Affiliated Hospital of Zhejiang University School of Medicine","Hangzhou","Zhejiang","310000",{"type":74,"coordinates":355},[356,357],120.16142,30.29365,{"lat":357,"lon":356},[360],{"name":361,"role":62,"phone":11,"phoneExt":11,"email":362},"Jie Jin","jiej0503@163.com",{"facility":364,"status":11,"city":351,"state":352,"zip":365,"country":71,"countryCode":72,"cosmosGeoPoint":366,"geoPoint":368,"contacts":369},"Zhejiang Cancer Hospital","310022",{"type":74,"coordinates":367},[356,357],{"lat":357,"lon":356},[370],{"name":371,"role":62,"phone":11,"phoneExt":11,"email":372},"Haiyan Yang","haiyanyang1125@163.com",{"type":374,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100653228","phase-3-a-phase-3-study-to-compare-the-efficacy-of-icp-248-in-combination-with-orelabrutinib-versus-pirtobrutinib-in-participants-with-relapsed-or-refractory-mantle-cell-lymphoma-rr-mcl-100653228",false,"NCT07784101","A Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r\u002Fr MCL).","A Randomized, Multicenter, Open-label, Phase 3 Study to Compare ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r\u002Fr MCL)","Inclusion Criteria:\n\n1. Known intolerance to orelabrutinib or pirtobrutinib treatment.\n2. Received autologous hematopoietic stem cell transplantation (ASCT) or cell therapy within 3 months prior to the first dose of the investigational product. Received allogeneic hematopoietic stem cell transplantation at any time in the past.\n3. Patients with other malignancies within 2 years prior to enrollment.\n4. Uncontrolled or significant cardiovascular disease.\n5. Hemophilia A, Hemophilia B, von Willebrand disease history or requiring the use of warfarin or equivalent vitamin K antagonist anticoagulants (such as phenprocoumon, etc.) or assessed by the investigator to have a tendency for spontaneous bleeding.\n6. Participants with severe central nervous system diseases.\n7. Participants with significant gastrointestinal dysfunction that may affect drug intake, transport, or absorption, or those who have undergone total gastrectomy.\n8. Underwent major surgery within 4 weeks prior to the first dose.\n9. Active infections require systemic treatment.\n10. Active autoimmune diseases.\n11. Known central nervous system lymphoma.\n12. Known alcohol or drug dependence.\n\nExclusion Criteria:\n\n1. Known intolerance to orelabrutinib or pirtobrutinib treatment.\n2. Received autologous hematopoietic stem cell transplantation (ASCT) or cell therapy within 3 months prior to the first dose of the investigational product. Received allogeneic hematopoietic stem cell transplantation at any time in the past.\n3. Patients with other malignancies within 2 years prior to enrollment.\n4. Uncontrolled or significant cardiovascular disease.\n5. Hemophilia A, Hemophilia B, von Willebrand disease history or requiring the use of warfarin or equivalent vitamin K antagonist anticoagulants (such as phenprocoumon, etc.) or assessed by the investigator to have a tendency for spontaneous bleeding.\n6. Participants with severe central nervous system diseases.\n7. Participants with significant gastrointestinal dysfunction that may affect drug intake, transport, or absorption, or those who have undergone total gastrectomy.\n8. Underwent major surgery within 4 weeks prior to the first dose.\n9. Active infections require systemic treatment.\n10. Active autoimmune diseases.\n11. Known central nervous system lymphoma.\n12. Known alcohol or drug dependence.","ALL","18 Years",{"count":385,"type":386},280,"ESTIMATED","INTERVENTIONAL",[389],"PHASE3","This study aims to compare the efficacy and safety of ICP-248 in combination with orelabrutinib versus pirtobrutinib in patients with relapsed or refractory mantle cell lymphoma (r\u002Fr MCL).",[392],"Relapsed or Refractory Mantle Cell Lymphoma (MCL)","NOT_YET_RECRUITING","2026-08-20",{"date":396,"type":397},"2026-08-25","ACTUAL",{"date":399,"type":386},"2026-10",{"date":401,"type":386},"2033-12",{"name":5,"class":6},24]